Target intelligence / Profile preview

Paracrine growth factor receptor

Molecular classification
Receptor, Receptor tyrosine kinase, Other
01

Overview

Paracrine growth factor receptors in surrounding tissues refer to a functional class of cell-surface proteins, primarily receptor tyrosine kinases, that mediate communication between different cell types within a local environment (PMID: 25207476). These receptors are expressed on cells such as endothelial cells, fibroblasts, and immune cells, and are activated by growth factors like VEGF, PDGF, or FGF secreted by neighboring cells (Nature Reviews Cancer, doi: 10.1038/nrc1272). In pathological states like cancer, tumor cells exploit these paracrine pathways to stimulate angiogenesis and stromal remodeling, which supports tumor progression and immune evasion (PubMed, PMID: 15057279). Similarly, in fibrotic diseases, paracrine activation of these receptors on fibroblasts leads to excessive extracellular matrix deposition and organ dysfunction. Therapeutic agents, including monoclonal antibodies like bevacizumab and small-molecule inhibitors like nintedanib, target these receptors to disrupt the supportive signaling network of the disease microenvironment (StatPearls, NBK482253). Because this term describes a broad signaling mechanism involving multiple distinct proteins rather than a single molecular entity, it is categorized as a functional group rather than a specific therapeutic target.

Other names
Stromal growth factor receptorsParacrine signaling receptorsGrowth factor receptors in the microenvironmentParacrine growth factor receptors in surrounding tissues
02

Mechanism of action

Inhibition of receptor tyrosine kinase activity or ligand-receptor binding to disrupt intercellular signaling pathways within the tissue microenvironment.

03

Biological functions

Signal transductionCell proliferationParacrine signalingAngiogenesisTissue remodelingCell migration
04

Disease associations

CancerFibrosisCardiovascular diseaseInflammation
05

Safety considerations

Impaired wound healingHypertensionGastrointestinal perforationHemorrhageProteinuriaArterial thromboembolic events
06

Interacting drugs

Bevacizumab

6 more in the full profile.

07

Biomarkers

VEGF expression levelsPDGF expression levelsMicrovessel densityReceptor phosphorylation statusFGF23 levels

Beyond the preview

Go deeper on Paracrine growth factor receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine growth factor receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call